Recalls and safety alerts from the FDA, newest first.
Revival Animal Health of Orange City, IA is recalling Breeder’s Edge® Foster Care® Canine, Shelter’s Choice® Canine Milk Replacers, and is expanding the current recall to include the Breeder’s Edge® Foster Care® GM (goat milk) products due to variable levels of Vitamin D resulting in either low or e
June 25, 2026, Lehi Valley Trading Company of Mesa, AZ, is recalling 624 units of its 15 ounce packages of High Valley Orchard Chocolate Covered Raisins because they contain undeclared peanuts. People who have allergies to peanuts run the risk of serious or life-threatening allergic reaction if they
Bear Stewart LLC of Chicago, IL is voluntarily recalling a single lot of Bakr Brown Butter Chocolate Chunk Ready To Bake Cookie Dough pouches because it may contain undeclared soy. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction i
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 150 units
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 4,944 tubes
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 450 units
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 84 tubes
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 3006 tubes
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 2503 tubes
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 1185 tubes
Subpotent Drug — IntegraDose Compounding Services LLC · Class II · Ongoing · 287 units
Failed Dissolution Specifications — Inventia Healthcare Limited · Class II · Ongoing · 11,460 bottles
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 150 units
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 1102 tubes
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 4,738 tubes
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 4374 tubes
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 — PAI Holdings LLC · Class II · Ongoing
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 — PAI Holdings LLC · Class II · Ongoing
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 — PAI Holdings LLC · Class II · Ongoing
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. — Ajanta Pharma USA Inc · Class II · Ongoing · 6,143 bottles
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 150 units
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 450 units
CGMP Deviations; deficiencies observed during FDA inspection — Dabur India Limited · Class II · Ongoing · 1225 tubes
Defective container:may contain bottles with incomplete seals — Keystone Industries · Class II · Ongoing · 150 units